Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR7967Referred to Committee

Heidi’s Law

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-03-17
Introduced
0
Cosponsors
HR
ⓘ
Type

Sponsor

Christopher H. Smith
Christopher H. Smith
Republican · NJ · Representative
Votes with party: 96.5% (548 recorded votes)

Full profile: /officials/S000522

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Oversight and Government Reform, and in addition to the Committee on Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2026-03-17

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Transportation and InfrastructureReferred To · 2026-03-17
  • House Committee on Oversight and Government ReformReferred To · 2026-03-17

Previously

  • Transportation and Infrastructure CommitteeReferred To · 2026-03-17
  • Oversight and Government Reform CommitteeReferred To · 2026-03-17

Plain-English Summary

I don't have enough information to write an accurate summary. The bill's title "Heidi's Law" doesn't indicate what policy it addresses, and the subjects listed (Government Operations and Politics) are too broad. To provide a meaningful explanation of what this bill would actually do and who it affects, I would need to see the bill's text or a more specific description of its provisions.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Government Operations and Politics

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7967 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7967 To require the Secretary of Health and Human Services to revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs to include testing for methadone use and to require the Secretary of Transportation to issue regulations to include testing for methadone use in Department of Transportation drug tests. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 17, 2026 Mr. Smith of New Jersey introduced the following bill; which was referred to the Committee on Oversight and Government Reform, and in addition to the Committee on Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To require the Secretary of Health and Human Services to revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs to include testing for methadone use and to require the Secretary of Transportation to issue regulations to include testing for methadone use in Department of Transportation drug tests. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as ``Heidi's Law''. SEC. 2. INCLUSION OF TESTING FOR METHADONE USE IN CERTAIN DRUG TESTING PROCEDURES. (a) Revision of Mandatory Guidelines.--Not later than 90 days after the date of enactment of this Act, the Secretary of Health and Human Services shall revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs, established pursuant to section 503(a) of Public Law 100-71 (5 U.S.C. 7301 note), to expand the opiate category on the list of substances authorized for testing to include methadone. (b) Publication of Notice.--Upon completion of the revision required under subsection (a), the Secretary shall publish a final notice in the Federal Register of such revision. SEC. 3. INCLUSION OF METHADONE IN DEPARTMENT OF TRANSPORTATION DRUG TESTS. Not later than 60 days after the final notice required under section 2(b) is published, the Secretary of Transportation shall issue such regulations as are necessary to update any regulations containing procedures for transportation employee workplace drug and alcohol testing programs to include testing for methadone use in drug-testing panels, consistent with the Mandatory Guidelines for Federal Workplace Drug Testing Programs as revised by the Secretary of Health and Human Services under section 2. SEC. 4. TO COMPEL THE SECRETARY TO PERIODICALLY UPDATE THE MANDATORY GUIDELINES FOR FEDERAL WORKPLACE DRUG TESTING. (a) In General.--On an annual basis, the Secretary of Health and Human Services shall review and if necessary revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs, established pursuant to section 503(a) of Public Law 100-71 (5 U.S.C. 7301 note), to expand the list of substances authorized for testing to include any such drugs which may not have been previously included, and which the Secretary believes should be included. (b) Publication of Notice.--Upon completion of the revision required under subsection (a), the Secretary shall publish a final notice in the Federal Register of such revision. SEC. 5. INCLUSION OF NEWLY ESTABLISHED DRUGS IN DEPARTMENT OF TRANSPORTATION DRUG TESTS. Not later than 60 days after the final notice required under section 4(b) is published, the Secretary of Transportation shall issue such regulations as are necessary to update any regulations containing procedures for transportation employee workplace drug and alcohol testing programs to include testing for newly identified substances in drug-testing panels, consistent with the Mandatory Guidelines for Federal Workplace Drug Testing Programs as revised by the…
Show the remaining 10 wordsHide the remaining 10 words
Secretary of Health and Human Services under section 4. <all>
Open clean-text viewRead on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR9085Tibet Atrocities Determination Act
    Referred to Committee · 2026-06-02
  • HR4348To reauthorize the Kay Hagan Tick Act, and for other purposes.
    Reported by Committee · 2026-05-21
  • HR5160Stem Cell Therapeutic and Research Reauthorization Act of 2025
    Referred to Committee · 2026-05-21
  • HRES1279Supporting the designation of the month of May as "Lyme and Tick-borne Disease Awareness Month".
    Referred to Committee · 2026-05-13